HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myocardial metabolism during intracoronary thrombolysis. Two illustrative cases.

Abstract
Arterial and coronary sinus difference for potassium, lactate, glucose, free fatty acids and creatine kinase was measured every 5 minutes in two patients undergoing successful intracoronary thrombolysis of left anterior descending occlusion. In the first patient, reperfusion, 160 minutes after the onset of pain, was followed by a transient and limited release of creatine kinase in the coronary sinus, improvement in the electrocardiogram and restitution of left ventricular contraction. In the second patient, reperfusion 365 minutes after the onset of pain, was also accompanied by a limited release of creatine kinase. Reocclusion of the left anterior descending coronary artery, however, necessitated further thrombolysis which led to a massive release of creatine kinase and permanent loss of wall-motion. It is suggested that, in this case, reperfusion damage had occurred. The arteriovenous differences showed a wash-out of potassium and lactate during reperfusion in each case. The interpretation of the entire sequence of arteriovenous changes, however, could be shown to depend critically on the state of regional perfusion.
AuthorsR Ferrari, L Niccoli, O Visioli, P Harris
JournalInternational journal of cardiology (Int J Cardiol) Vol. 15 Issue 3 Pg. 293-9 (Jun 1987) ISSN: 0167-5273 [Print] Netherlands
PMID3596835 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Lactates
  • Lactic Acid
  • Creatine Kinase
  • Urokinase-Type Plasminogen Activator
  • Potassium
Topics
  • Blood Glucose (analysis)
  • Coronary Disease (drug therapy, metabolism)
  • Creatine Kinase (blood)
  • Fatty Acids, Nonesterified (blood)
  • Female
  • Humans
  • Lactates (blood)
  • Lactic Acid
  • Male
  • Middle Aged
  • Myocardium (metabolism)
  • Potassium (blood)
  • Time Factors
  • Urokinase-Type Plasminogen Activator (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: